LipoFluidics® a unique liposomal delivery system
Over the last decade Spectrumceuticals® have been conducting research and development into liposomal technologies through third party laboratories. In 2022, we commenced building from green field a new state of the art research and development facility including a pilot scale laboratory. As of 2024, the pilot laboratory is been scaled up to a complete cleanroom with cGMP manufacturing facilities for 2025. We will keep you posted as developments occur.
We have developed a uniform propriety liposomal delivery system using high quality ingredients with microfluidizer technology and in process PCS validation to transport active ingredients in nutritional supplementation.
From research to application LipoFluidics® is a unique method of forming liposomes with a uniform size distribution, and an average size of 60 nm or less
An advanced nanoparticle delivery system formed within phospholipid bilayers for a broad spectrum of bioactive compounds.